Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

6 Stocks, 3 Mergers, and 1 Unhappy Activist

Page 1 of 2

With many investors expecting the Fed to raise rates this week and the high yield bond market beginning to show signs of rolling over, several new and pending merger stocks are trending today. In this article we take a closer look at Baker Hughes Incorporated (NYSE:BHI), Halliburton Company (NYSE:HAL), Jarden Corp (NYSE:JAH), Newell Rubbermaid Inc. (NYSE:NWL), Dow Chemical Co (NYSE:DOW), and E I Du Pont De Nemours And Co (NYSE:DD), as each stock trends on the latest news surrounding their proposed mergers.

Moreover, we will also examine relevant hedge fund sentiment toward each of these equities. In the eyes of most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are more than 8,000 funds in operation at present, hedge fund experts at Insider Monkey look at the aristocrats of this group, around 730 funds. Contrary to popular belief, Insider Monkey’s research revealed that hedge funds underperformed in recent years because of their short positions as well as the huge fees that they charge. Hedge funds managed to outperform the market on the long side of their portfolios. In fact, the 15 most popular small-cap stocks among hedge funds returned 102% since the end of August 2012 and beat the S&P 500 Index by 53 percentage points (see the details here).

With crude prices taking another leg lower today, Baker Hughes Incorporated (NYSE:BHI) and Halliburton Company (NYSE:HAL) are in the spotlight after Reuters published a report stating that EU regulators have competition concerns over the two oil service giants’ prospective tie-up. Although Halliburton has already agreed to divest over $5 billion in overlapping businesses to lessen the concerns, the EU regulators may want even more concessions. Halliburton executives are scheduled to meet with EU regulators next week to discuss the deal and the preliminary EU regulator scrutiny should end on January 12. Although Baker Hughes Incorporated (NYSE:BHI) and Halliburton Company (NYSE:HAL) shares are both in the red year-to-date because of the low crude prices weakening oil service demand, their shares have done better than their peers thanks to the merger. If the merger is nixed, however, the two companies will not be able to achieve the substantial synergies promised and their shares could take big dips, as evidenced today by the mere speculation that the deal could be in jeopardy; BHI shares are down by 6.69%, while Halliburton shares have fallen by just over 1%.

Follow Baker Hughes Inc (NYSE:BHI)
Trade (NYSE:BHI) Now!

Capping off a successful decade-and-a-half bull run, Jarden Corp (NYSE:JAH) has agreed to merge with Newell Rubbermaid Inc. (NYSE:NWL) in a deal that will produce a $16 billion-a-year consumer goods giant named ‘Newell Brands’. Under the terms of the deal, Jarden Corp (NYSE:JAH) shareholders will receive $21 in cash and 0.862 Newell Rubbermaid Inc. (NYSE:NWL) shares for each Jarden share they own. Management expects the deal to generate around $500 million in cost synergies over four years and to be immediately accretive to normalized EPS. Because of the deal, Jarden shares have surged by 4.31% today, while Newell shares have retreated by 5.7%. Among the winners in the merger announcement is Larry Robbins’ Glenview Capital, which owned 4.03 million shares of Jarden at the end of September.

Follow Halliburton Co (NYSE:HAL)
Trade (NYSE:HAL) Now!

On the next page, we examine the Dow Chemical Co. and Dupont merger, which has one activist not at all pleased.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!